Omeprazole 80 mg twice daily for prostatic neoplasms, castration-resistant

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Apr 2020: Trial registered, NCT04337580
  2. 5 Mar 2021: Trial started, NCT04337580

The trials

NCT04337580: Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

State
Under way
Phase
Phase 2
People
50 planned
Started
5 Mar 2021
Primary completion
Feb 2028
Arms
Omeprazole Plus Standard of Care for Prostate Cancer Regimen
Results
None posted
  1. 7 Apr 2020: Trial registered
  2. 5 Mar 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.